Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Clinical and Vaccine Immunology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Archive
  • About the Journal
    • About CVI
    • For Librarians
    • For Advertisers
    • FAQ
Diagnostic Laboratory Immunology

A Novel Line Immunoassay Based on Recombinant Virulence Factors Enables Highly Specific and Sensitive Serologic Diagnosis of Helicobacter pylori Infection

Luca Formichella, Laura Romberg, Christian Bolz, Michael Vieth, Michael Geppert, Gereon Göttner, Christina Nölting, Dirk Walter, Wolfgang Schepp, Arne Schneider, Kurt Ulm, Petra Wolf, Dirk H. Busch, Erwin Soutschek, Markus Gerhard
Luca Formichella
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Romberg
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Bolz
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Vieth
cDepartment of Pathology, Klinikum Bayreuth, Bayreuth, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Geppert
bDoctor's Practice for Gastroenterology, Bayreuth, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gereon Göttner
dMikrogen GmbH, Neuried, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christina Nölting
dMikrogen GmbH, Neuried, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Walter
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Schepp
eDepartment of Gastroenterology, Hepatology and Gastrointestinal Oncology, Bogenhausen Academic Teaching Hospital, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arne Schneider
eDepartment of Gastroenterology, Hepatology and Gastrointestinal Oncology, Bogenhausen Academic Teaching Hospital, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Ulm
fInstitute for Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Wolf
fInstitute for Medical Statistics and Epidemiology, Technische Universität München, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk H. Busch
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
gDZIF German Centre for Infection Research, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erwin Soutschek
dMikrogen GmbH, Neuried, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus Gerhard
aInstitute for Medical Microbiology, Immunology and Hygiene, Technische Universität München, Munich, Germany
gDZIF German Centre for Infection Research, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/CVI.00433-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    Total score points of patients showing different IgG immune responses. The antigens CagA, VacA, and GroEL score 2 points when positive. The antigens UreA, HcpC, and gGT score 1 point when positive. The total score (∑) reaches 9 points when all antigen bands show up, as illustrated in strip 5. The test is considered positive with a score of 2 or more. If only one antigen with 1 score point shows a band, the result is judged to be borderline and the test should be repeated.

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    Results for detected immune responses of positive and negative sera verified by histology. The test is able to differentiate between type I and type II strain infections with the antigens CagA and VacA. In the top row, conjugate controls for detection of antibody (IgG) are included, serving as a positive control. To be able to discriminate the antigen bands from background staining, a cutoff control is included.

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    Antigen frequencies in the positive cohort. In total, 210 H. pylori-positive patients were tested. The antigens CagA and GroEL showed the highest recognition rates. Immune responses against HcpC and gGT were rather frequent, but the antigens VacA and UreA showed relatively low recognition rates.

Tables

  • Figures
  • Additional Files
  • Table 1

    Characteristics of the 500 patients included in the study

    CharacteristicValue
    HistologyTotal
    NegativePositive
    Total no. (%)290 (58.0)210 (42.0)500 (100)
    Age (yr)
        Mean value48.552.350.1
        SD16.016.216.2
        Minimum18.018.018.0
        Maximum86.086.086.0
    Gender [no. (%)]
        Female154 (53.1)109 (51.9)263 (52.6)
        Male136 (46.9)101 (48.1)237 (47.4)
  • Table 2

    Performances of serological tests for the 500 cases included in the study

    ParameterPerformance [% (no./total)]
    recomLinerecomWellImmunoblot
    Sensitivity97.6 (205/210)86.2 (181/210)85.2 (179/210)
    Specificity96.2 (279/290)95.5 (277/290)97.9 (284/290)
    PPV94.592.796.4
    NPV98.491.290.8
  • Table 3

    Comparison of different serological tests (recomLine, Immunoblot Helicobacter, and recomWell) to histology for detection of H. pylori infectiona

    HistologyrecomLineImmunoblotrecomWellNo./total
    −−−−264/290
    −−+−2/290
    −−−+12/290
    −+−−8/290
    −−++1/290
    −++−3/290
    −+−+0/290
    −+++0/290
    ++++161/210
    +++−18/210
    ++−+20/210
    ++−−6/210
    +−−−5/210
    +−+−0/210
    +−−+0/210
    +−++0/210
    • ↵a −, negative; +, positive.

Additional Files

  • Figures
  • Tables
  • Supplemental material

    Files in this Data Supplement:

    • Supplemental file 1 -

      Table S1. Primers used for amplification and cloning of H. pylori virulence factor genes. Fig. S2. Elution profile of the gel filtration run for HcpC and SDS-PAGE with the relevant fractions 9, 10, and 11. Fig. S3. Elution profile of the gel filtration run for recombinant gGT on the left side and SDS-PAGE with the relevant fractions. Table S4. Different expressed H. pylori proteins, the attached Tag for purification, and the purification steps with purity and concentration. Fig. S5. Evaluation process for CagA, measuring IgG antibodies from sera. Fig. S6. Evaluation process for VacA, measuring IgG antibodies from sera. Fig. S7. Evaluation process for GroEL, measuring IgG antibodies from patient sera. Fig. S8. Evaluation process for UreA, measuring IgG antibodies from sera. Fig. S9. Evaluation process for HcpC, measuring IgG antibodies from sera. Fig. S10. Evaluation process for gGT, measuring IgG antibodies from sera. Fig. S11. Evaluation process for UreB, Omp18, and ICD, measuring IgG antibodies from sera.

      PDF, 1.7M

PreviousNext
Back to top
Download PDF
Citation Tools
A Novel Line Immunoassay Based on Recombinant Virulence Factors Enables Highly Specific and Sensitive Serologic Diagnosis of Helicobacter pylori Infection
Luca Formichella, Laura Romberg, Christian Bolz, Michael Vieth, Michael Geppert, Gereon Göttner, Christina Nölting, Dirk Walter, Wolfgang Schepp, Arne Schneider, Kurt Ulm, Petra Wolf, Dirk H. Busch, Erwin Soutschek, Markus Gerhard
Clinical and Vaccine Immunology Oct 2013, 20 (11) 1703-1710; DOI: 10.1128/CVI.00433-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Email

Thank you for sharing this Clinical and Vaccine Immunology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel Line Immunoassay Based on Recombinant Virulence Factors Enables Highly Specific and Sensitive Serologic Diagnosis of Helicobacter pylori Infection
(Your Name) has forwarded a page to you from Clinical and Vaccine Immunology
(Your Name) thought you would be interested in this article in Clinical and Vaccine Immunology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Novel Line Immunoassay Based on Recombinant Virulence Factors Enables Highly Specific and Sensitive Serologic Diagnosis of Helicobacter pylori Infection
Luca Formichella, Laura Romberg, Christian Bolz, Michael Vieth, Michael Geppert, Gereon Göttner, Christina Nölting, Dirk Walter, Wolfgang Schepp, Arne Schneider, Kurt Ulm, Petra Wolf, Dirk H. Busch, Erwin Soutschek, Markus Gerhard
Clinical and Vaccine Immunology Oct 2013, 20 (11) 1703-1710; DOI: 10.1128/CVI.00433-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About CVI
  • For Librarians
  • For Advertisers
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • Submit a Manuscript to mSphere

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 1556-6811; Online ISSN: 1556-679X